, Decision_act (EU) 2004/104

In forcesince 27 Nov 2002

Commission Decision

of 27 November 2002

relating to a proceeding pursuant to Article 81 of the EC Treaty and Article 53 of the EEA Agreement

(Case COMP/E-2/37.978/Methylglucamine)

(notified under document number C(2002) 4557)

(Only the German and French texts are authentic)

(Text with EEA relevance)

(2004/104/EC)

CONTENTS

>TABLE>

SUMMARY

Addressees

This Decision is addressed to the following undertakings:

–

Rhône-Poulenc Biochimie SA

–

Aventis Pharma SA

–

Merck KgaA

Articles infringed

Article 81(1) of the EC Treaty and Article 53 of the EEA Agreement prohibiting all agreements between undertakings, decisions by associations of undertakings and concerted practices which may affect trade between Member States and the contracting parties to the EEA Agreement and which have as their object or effect the prevention, restriction or distortion of competition within the common market and within the territory covered by the EEA Agreement.

Relevant product

Methylglucamine of pharmaceutical quality used as an intermediate chemical product for the synthesis of x-ray media, pharmaceuticals and colourings.

Community market value

Approximately EUR 3,1 million annually(1).

Specification of the infringement

Beginning in November 1990 and continuing until December 1999 the main producers of methylglucamine formed a clandestine cartel contrary to Article 81(1) of the Treaty and Article 53(1) EEA covering the Community and the EEA, by which they fixed market shares for the product; agreed on price targets for the product; agreed on price lists for the product and agreed on how to share the largest customers.

Duration of the participation

–

Merck KgaA from 22 November 1990 to 31 December 1999

–

Rhône-Poulenc Biochimie SA from 22 November 1990 to 31 December 1999

–

Aventis Pharma SA from 22 November 1990 to 31 December 1999.

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the treaty establishing the European Community,

Having regard to the Agreement of the European Economic Area,

Having regard to Council Regulation No 17 of 6 February 1962, first Regulation implementing Articles 85 and 86 of the Treaty(2), as last amended by Regulation (EC) No 1/2003(3), and in particular Articles 3 and 15 thereof,

Having regard to the Commission decisions of 1 October 2001 and 17 December 2001 to open a proceeding in this case,

Having given the undertakings concerned the opportunity to make known their views on the objections raised by the Commission pursuant to Article 19(1) of Regulation No 17 and Commission Regulation (EC) No 2842/98 of 22 December 1998 on the hearing of parties in certain proceedings under Articles 85 and 86 of the EC Treaty(4),

Having consulted the Advisory Committee on Restrictive Practices and Dominant Positions,

Having regard to the report of the hearing officer in this case(5),

Whereas: